Published in Am J Nephrol on January 01, 1999
Mechanisms of progression of chronic kidney disease. Pediatr Nephrol (2007) 1.52
The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4). World J Gastroenterol (2000) 1.43
Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl Environ Microbiol (2000) 1.24
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? Drugs Context (2013) 0.86
Rituximab treatment of idiopathic membranous nephropathy. Kidney Int (2007) 2.85
Identifying specific causes of kidney allograft loss. Am J Transplant (2008) 2.77
The histology of solitary renal allografts at 1 and 5 years after transplantation. Am J Transplant (2010) 2.40
Kidney allograft survival after acute rejection, the value of follow-up biopsies. Am J Transplant (2013) 2.35
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging (2013) 2.27
Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients. Am J Transplant (2011) 1.98
Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg (1990) 1.90
Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant (2006) 1.83
Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant (2009) 1.71
Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant. Am J Transplant (2006) 1.70
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant (2010) 1.56
Effects of feeding on protein turnover in healthy children and in children with cystic fibrosis. Am J Clin Nutr (1996) 1.52
Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis (1996) 1.47
Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant (2006) 1.42
Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant (2007) 1.40
Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract (1993) 1.38
Patient survival after renal transplantation: I. The impact of dialysis pre-transplant. Kidney Int (1998) 1.37
Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr (1983) 1.30
Characterization of somatostatin receptors on human neuroblastoma tumors. Cell Growth Differ (1994) 1.30
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel. Dig Dis Sci (1995) 1.29
Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant (2007) 1.25
Effect of a long-acting somatostatin analogue (SMS 201-995) in a patient with pancreatic cholera. N Engl J Med (1985) 1.24
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative. Am J Transplant (2004) 1.23
Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int (2006) 1.23
Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group. Kidney Int (1996) 1.20
Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate. Am J Transplant (2007) 1.19
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol (1983) 1.13
Urine high and low molecular weight proteins one-year post-kidney transplant: relationship to histology and graft survival. Am J Transplant (2013) 1.12
Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant (2006) 1.12
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology (1988) 1.09
Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant (2008) 1.07
Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg (1990) 1.07
Effect of octreotide acetate on pancreatic exocrine function. Am J Surg (1989) 1.06
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Specific binding sites for vasoactive intestinal polypeptide on nonadherent peripheral blood lymphocytes. J Immunol (1983) 1.03
Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol (1991) 1.02
Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int (1989) 1.01
Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome. Peptides (1993) 1.01
Association of thin glomerular basement membrane with other glomerulopathies. Kidney Int (1994) 1.01
Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int (1992) 1.00
Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res (1991) 0.99
Vasoactive intestinal polypeptide modulation of lymphocyte adenylate cyclase. J Immunol (1981) 0.99
Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe. Surgery (1993) 0.98
Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones. Ann Intern Med (1985) 0.98
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Circulation (1993) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Intraoperative localization of intestinal arteriovenous malformation. Arch Surg (1978) 0.97
Early surgical treatment of gastrinoma. Am J Med (1987) 0.97
Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med (1983) 0.97
Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995. Lancet (1986) 0.96
Renoprotection: one or many therapies? Kidney Int (2001) 0.96
Prevention of postprandial hypotension with somatostatin. Ann Intern Med (1985) 0.96
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. Am J Med (1986) 0.96
Display of arteriovenous anastomoses by double latex injection after vasodilatation with chloroform. Microvasc Res (1970) 0.96
Loin pain-hematuria syndrome associated with thin glomerular basement membrane disease and hemorrhage into renal tubules. Kidney Int (1996) 0.96
Protocol biopsies in renal transplantation: insights into patient management and pathogenesis. Am J Transplant (2007) 0.96
Mechanisms of action of long-acting analogs of somatostatin. Regul Pept (1993) 0.95
Soluble immune complexes binding to human monocytes and polymorphonuclear leucocytes. Immunology (1981) 0.95
Gastric inhibitory polypeptide (GIP). Intestinal distribution and stimulation by amino acids and medium-chain triglycerides. Am J Dig Dis (1976) 0.95
Somatostatin receptor gene expression in neuroblastoma. Regul Pept (2000) 0.94
Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass. Surgery (1986) 0.94
Gastric response to severe head injury. Am J Surg (1984) 0.93
Chronic renal failure: effect of hemodialysis on gastrointestinal hormones. Am J Surg (1984) 0.93
Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients. Diabetes (1990) 0.93
Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant (1999) 0.93
The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant (2012) 0.93
The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci (1995) 0.93
Vasoactive intestinal polypeptide as a biochemical marker for polymorphonuclear leukocytes. J Lab Clin Med (1980) 0.93
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man. Gastroenterology (1977) 0.93
Renal effects on serum gastric inhibitory polypeptide (GIP). Metabolism (1977) 0.92
Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant (2008) 0.92
Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors. Surg Gynecol Obstet (1988) 0.92
Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans. J Am Soc Nephrol (1996) 0.92
Severe renal failure in multiple myeloma. Clin Nephrol (1981) 0.92
Obese living kidney donors: short-term results and possible implications. Transplantation (1999) 0.92
Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome. J Clin Endocrinol Metab (1981) 0.92
Fragmented electrograms and continuous electrical activity in atrial flutter. Am J Cardiol (1986) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. N Engl J Med (1981) 0.91
GI hormonal changes in diabetes influence pancreatic cancer growth. J Surg Res (1995) 0.91
Thirty years' experience with gastrinoma. World J Surg (1984) 0.91
Characterization of the baboon erythrocyte C3b-binding protein. J Immunol (1989) 0.91
Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes. J Lab Clin Med (1984) 0.90
Long-term treatment of refractory neonatal hypoglycemia with long-acting somatostatin analog. J Pediatr (1987) 0.90
Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab (1999) 0.90
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
Treatment of hypercalcemia associated with malignancy. Semin Oncol (1978) 0.89
Atheroembolic renal disease causes hypocomplementaemia. Lancet (1985) 0.89
Angiotensin II and norepinephrine antagonize the secretory effect of VIP in rat ileum and colon. Peptides (1984) 0.89
Impact of acute rejection and early allograft function on renal allograft survival. Transplantation (1997) 0.89
Decreased serum C-peptide/insulin molar ratios after oral glucose ingestion in hyperthyroid patients. Diabetes Care (1984) 0.89